Dinner with Bob! There are many reasons to admire Bob Langer. He reminds us that the most successful people can also be the most humble ones! 🙏🏽

Congrats to Natalie Artzi for her induction into the 2024 Class of the AIMBE College of Fellows. She is honored for her contributions to understanding interactions of nanostructures w/ the immune system and engineering of disease-responsive biomaterials for diagnosis/therapy.

We’re looking for PhD students studying the life sciences or biomedical research outside the US to apply for the Amon Young Scientist Award. Winners will be invited to the Koch Institute to give a presentation and meet our researchers. Apply by May 31: ki.mit.edu/events/prizes-…

Happy to see this special issue on cancer as part of Cell’s #50YearsofCell celebration!

Interesting talk from a very talented postdoc Larissa Carvalho on targeting Ras in NRAS-mutant melanoma using RASMULTI(ON) inhibitor RMC-7977 at AACR tomorrow. Check it out!

During the AACR Opening Ceremony, Kimryn Rathmell, MD, PhD, (Dr. Anthony Letai) shouted out Moffitt Cancer Center for our pivotal role in the U.S. FDA approval of TIL for solid tumors. We are proud to be one of the first centers outside of National Cancer Institute to treat patients with this

While at #AACR24, stop by booth 1510 to meet Moffitt team members and learn about the impact Moffitt is making in cancer research, outcomes and advancements. #MoffittAACR24

Receiving the Public Welfare Medal sends "a clear message that women are essential to America's scientific mission and excellence," says Nancy Hopkins as she closes her acceptance speech. "It's a historic statement." #NASAward #NAS161 youtube.com/watch?v=5hNQt4…

Join Moffitt’s Alexander Anderson, PhD (Sandy Anderson) tomorrow at #SMB2024 for a discussion on evolutionary therapy during the plenary session. ⏰: 7/1 from 9-9:40 a.m. KST 📍: New Millenium Hall Learn more ➡️ bit.ly/4cGASY1

Tomorrow at #SMB2024: Moffitt’s Daniel Glazer, PhD presents the latest in predicting tumor volume changes and survival in recurrent high-grade Glioma during the minisymposia session. ⏰: 7/1 from 2-3:40 p.m. KST 📍: #318(3F) Learn more ➡️ bit.ly/3VEPz6W

Tomorrow at #SMB2024: Kit Gallagher (Kit Gallagher) presents the latest in personalized cancer treatments using mathematical modeling at the minisymposia session. ⏰: 7/1 from 4-5:40 p.m. KST 📍: #221(2F) Learn more ➡️ bit.ly/3VK6HIv

Excited to announce that registration for the 12th IMO workshop on Treatment Toxicity is now open. Held onsite Moffitt Cancer Center Nov 3-Nov 8 #MoffittIMO more details: imo12.eventbrite.com. Deluxe travel awards are available on a competitive basis, apply by 09/30!

New PICI-funded research from Dana-Farber and MIT has unveiled an innovative antigen-based imaging approach enabling whole-body and real-time CAR T cell imaging, published recently in Science Magazine: science.org/doi/10.1126/sc… (1/3)

This is a nice summary of the mechanisms of action of various KRAS inhibitors from Adrienne Cox & Channing Der in their Science Magazine perspective.

Congratulations, Kedar Kulkarni and Issam El Naqa on your graduation from Moffitt’s Leadership Academy! It’s clear from the presentations by you and your fellow cohort members that Moffitt’s future is bright!

Today at the @RivkinCenter AACR Ovarian Cancer Research Symposium Moffitt’s Erin George MD (Erin George) presents on drug screening using 3D microtissues to enhance treatment strategies for ovarian cancer during the poster session. ⏰: 9/20 2:30 p.m. PDT 📍: Washinton

Two summary graphics in the AACR #CancerProgressReport 2024: A: The notable rise in early onset #ColorectalCancer incidence & mortality over the past 5y B: The expanding scope of #immunotherapy across solid cancers, still missing #PancreaticCancer. cancerprogressreport.aacr.org/wp-content/upl…

Just kicked off the 2025 Scientific Symposium Moffitt Cancer Center! The annual event highlights the incredible work of our researchers and trainees across basic, quantitative, translational, population and clinical sciences. Great day including oral presentations and poster sessions

Then Jill Gallaher Sandhya Prabhakaran Chandler Gatenbee and Masud m.a. present Adaptive therapy for castrate sensitive prostate cancer, TIL therapy in NSCLC, CAR-T in lymphoma and tissue homeostasis in Basal Cell Carcinoma #AndersonLab IMO Moffitt Cancer Center